Highlights Sientra, Inc.

Equities

SIEN

US82621J2042

Delayed OTC Markets Other stock markets 09:30:17 2024-04-29 am EDT			5-day change	1st Jan Change
0.0725 ^USD	-27.43%		+11.54%	-88.11%

Apr. 15	Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.	CI
Apr. 11	North American Morning Briefing : Stock Futures -2-	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Stock Futures -2-	Apr. 11	DJ
Earnings Flash (SIEN) SIENTRA Reports Q3 Revenue $19.5M	Nov. 09	MT
Sientra, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Sientra, Inc. Provides Revenue Guidance for the Third Quarter of 2023	23-10-30	CI
Sientra, Inc. Revises Earnings Guidance for the Full Year 2023	23-08-10	CI
Earnings Flash (SIEN) SIENTRA Reports Q2 Revenue $23.1M, vs. Street Est of $25M	23-08-10	MT
Sientra, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Sientra, Inc. Appoints Alexander W. Casdin to the Companyâ€™s Board of Directors, Effective June 15, 2023	23-06-20	CI
Sientra Says US FDA Clears AlloX2 Pro Tissue Expander; Shares Rise Premarket	23-06-09	MT
Sientra Says US FDA Clears AlloX2 Pro Tissue Expander; Shares Jump	23-06-08	MT
Sientra Announces FDA-Clearance of Next Generation Allox2 Pro Tissue Expander	23-06-08	CI
Sientra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Earnings Flash (SIEN) SIENTRA Reports Q1 Revenue $22.6M, vs. Street Est of $22.9M	23-05-11	MT
Sientra, Inc. Provides Earnings Guidance for the Full Year of 2023	23-05-11	CI
Sientra, Inc. Provides Revenue Guidance for the First Quarter and Earnings Guidance for the Full Year of 2023	23-03-30	CI
Sientra, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-30	CI
Earnings Flash (SIEN) SIENTRA Posts Q4 Revenue $25.1M, vs. Street Est of $25.2M	23-03-30	MT
Aziyo Biologics and Sientra Announce SimpliDerm(R) Partnership to Improve Women's Access to Biologics for Soft Tissue Reconstruction	23-03-22	CI
Sientra Announces Preliminary Results from Clinical Study and the First Shipment of Viality Fat Transfer System	23-03-01	CI
Sientra Board Approves 1-for-10 Reverse Stock Split	23-01-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sientra, Inc.

Equities

SIEN

US82621J2042

Highlights

Filters